FP6Reintegration grant2006–2008

AMT PROTEOMICS · High throughput proteomics using accurate mass and time tags

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-02-01 → 2008-01-31
EU contribution
€80,000
Participants
1
Scheme
IRG

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

Final Activity Report Summary - AMT PROTEOMICS (High throughput proteomics using accurate mass and time tags)

In the age of routine genome sequencing, biologists increasingly turn their gaze towards the molecular effectors of living organisms. Messenger ribonucleic acids (mRNA), which transcribe the genetic code, and proteins, ultimate translations of their messages, are now probed to decipher the secrets of life. While the genome can be considered more or less static, gene expressions in the form of mRNA and their translation into proteins are highly dynamic processes subject to a great variety of internal and environmental stimuli. For this reason, transcriptomics (i.e. the study of mRNA) and proteomics (i.e. the study of proteins) require broad scale assays on large numbers of samples. Proteomics technology is rapidly evolving, being largely driven by applications in biomarkers discovery for early disease diagnostics and therapeutics. The greatest challenges in proteomics research reside in the high degree of complexity of biological samples and their extended dynamic range. According to the Human Proteome Initiative, the 21 000 human genes encode about one million different proteins. Moreover, the broad abundance range spanned by these proteins makes proteomic analyses very challenging. As an example, relative protein concentrations in human plasma cover an estimated 1010 orders of magnitudes. Measuring such diversity could be compared to using the same balance to weight an elephant and a mosquito. Modern proteomic analyses approaches most often rely on mass spectrometry (MS) to derive protein identification and quantification. MS is a chemical analysis method designed to measure the molecular weight of chemical species. MS can also probe chemical structures in a mode known as tandem mass spectrometry or MS/MS. MS is typically used after protein digestion: A specific enzyme (e.g. trypsin) cleaves proteins at particular positions along their sequence to produces a mixture of peptides (small protein fragments). Conventional proteomics methodologies rely on protein library search after obtaining (partial) knowledge of peptide sequence through LC-MS/MS. Such methods suffer from intrinsic limitations such as analyte under sampling. In fact, detected peptides tend to be highly abundant whereas many lower-abundant ones are not consistently sampled. To overcome these issues, innovative strategies have been developed allowing peptides identification based on LC retention time and accurate mass. These methods, coined as 'Accurate mass & time (AMT) tags', have recently showed great promise for proteomics research. Exploring new approaches to study biological samples is crucial not only in fundamental studies but also for biomedical research. With the support of a Marie Curie International Reintegration Grant funded by the European Union, the CEA Grenoble (France) has hired an expert in AMT technology, who worked previously at PNNL with R. D. Smith, the inventor of this innovative technology. With the installation of a EUR 1 million state-of-the-art instrumentation platform, and the constitution of a dedicated team, the CEA has successfully implemented the AMT technique. Through the study of a model plant biology system, the A. thaliana chloroplast envelope, the methodology was implemented and thoroughly tested. This research provided the first chloroplast protein database; which is being put to use to determine the function of chloroplastic proteins by comparing protein profiles from diverse A. thaliana mutants (collaboration with N. Rolland and collaborators at CEA). The method has since been used to establish differential protein abundance profiles between micro dissected cholangiocarcinoma and their healthy counterparts (collaboration with C. Bréchot and collaborators at INSERM). Several biomarker candidates, which emerged from this study, are being investigated by clinicians to improve our understanding of this deadly disease.

Data: CORDIS, © European Union

Project objective

The environment of a given organism determines the dynamics of gene expression, post-translational modifications of proteins and their interactions. Proteomics and genomics approaches now allow capturing these dynamics, which govern the life of an organism. Proteomics is devoted to the systematic study of proteins in order to derive a global perspective of the structures, functions and regulatory mechanisms in biological systems. The proteome represents the entire protein complement of a cell or a tissue a t a given time, in given environmental, physiological and/or pathological conditions. The dynamic nature of the proteome constitutes one of the major hurdles of proteomics analyses. Whereas the analysis of a single sample can potentially provide all the genetic information about an organism, a multitude of analyses in various conditions are necessary for proteome studies. Recent years have seen an intensive development in proteomics methodologies.Among these, accurate mass and time (AMT) tag based proteomic is particularly promising to provide extensive proteome coverage with high throughput. An AMT tag database is established by using standard proteomics methods to identify peptides and their parent proteins. Identifications are then validated using accurate masses obtained by Fourier Transform Mass Spectrometry (FTMS) and Liquid Chromatography (LC) retention times. The AMT tag database obviates the need for MS/MS in all subsequent analyses, providing the basis for throughput improvements. We are getting involved in a large-scale effort to implement and develop AMT-tag based methods.Our strategy includes new technological developments and biological applications. We plan to improve the method's quantitative ability, and to promote the use of alternative ion dissociation methods to study post-translational modifications. Initial applications include studies of the membrane from A. thaliana chloroplasts and of a mouse model of the graft vs host disease.

Original text from CORDIS.

Participants

  • COMMISSARIAT L'ENERGIE ATOMIQUE · PARISCoordinatorCity levelFrance

Links

Data: CORDIS, © European Union